Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Vaccine-maker AstraZeneca claims victory in court tussle with EU over slow deliveries

06/18/2021 | 08:24am EDT

BRUSSELS (AP) — Vaccine-maker AstraZeneca claims victory in court tussle with EU over slow deliveries.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about ASTRAZENECA PLC
01:15pExclusive - AstraZeneca exploring options for COVID-19 vaccine business - exe..
RE
12:05pAstraZeneca COVID-19 sales jump as drugmaker navigates vaccine challenges
RE
11:01aASTRAZENECA : to seek US approval of COVID vaccine in 2nd half
AQ
10:51aASTRAZENECA : COVID-19 Jabs Supplied to Canada, Mexico From US Before Inspection..
MT
10:41aExclusive-AstraZeneca COVID-19 vaccine shipped to Canada, Mexico before adequ..
RE
10:41aASTRAZENECA : COVID-19 vaccine shipped to Canada, Mexico before adequate plant i..
RE
10:23aLondon Indexes Boosted by Positive Welcome to Most Earnings
DJ
10:06aASTRAZENECA : Oshikoto Youth Vaccine Hesitant
AQ
10:02aASTRAZENECA : H1 2021 results - AstraZeneca PLC
AQ
10:01aGLOBAL MARKETS LIVE : Earnings reports please investors
More news
Financials (USD)
Sales 2021 34 406 M - -
Net income 2021 6 268 M - -
Net Debt 2021 25 087 M - -
P/E ratio 2021 21,6x
Yield 2021 3,47%
Capitalization 128 B 179 B -
EV / Sales 2021 4,46x
EV / Sales 2022 3,47x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Last Close Price 82,77 $
Average target price 132,62 $
Spread / Average Target 60,2%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC12.86%177 726
JOHNSON & JOHNSON9.40%453 418
ROCHE HOLDING AG12.49%332 374
PFIZER, INC.18.04%243 220
ELI LILLY AND COMPANY46.00%224 084
NOVARTIS AG0.39%223 750